Lee JM, Miller A, Rose PG, AlHilli M, et al. Comparing durvalumab, olaparib, and cediranib monotherapy, combination therapy, or chemotherapy in patients with platinum-resistant ovarian cancer with prior bevacizumab: the phase II NRG-GY023 trial. Clin Cancer Res 2025 Apr 7. doi: 10.1158/1078-0432.CCR-24-3877.
PMID: 40192715